2don MSN
Molecular profiling of renal medullary carcinoma identifies TROP2 as a promising therapeutic target
Researchers at The University of Texas MD Anderson Cancer Center, in collaboration with BostonGene, conducted the largest and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback